Toft Group Completes Search for Chief Technology Officer for ImpediMed Ltd. in Carlsbad, CA

Executive search firm Toft Group has placed Mr. Sashi Tripathi as Chief Technology Officer at ImpediMed Ltd. (ASX: IPD), in ImpediMed’s US office in Carlsbad, CA.

Mr. Tripathi is an accomplished healthcare technology leader. As the SVP of Technology & Operations of New Century Health, he oversaw all aspects of IT, project and product management, product development and operations. He joined New Century Health from Springfield Clinic where he was the Chief Information Officer responsible for strategy, development, management and integration of the organization. Previously, Mr. Tripathi was the VP of IT for Facey Medical.

Earlier in his industry career, Mr. Tripathi served as a Product Development Consultant for Agnity Healthcare and as Global IT Director for St. Jude Medical. Mr. Tripathi holds an MS in Industrial Engineering & Operations Research from the Indian Institute of Technology and a BE in Mechanical Engineering from M.M.M. Engineering College.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About ImpediMed, Ltd.

Founded and headquartered in Brisbane, Australia with US and European operations, ImpediMed is the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of tissue composition and fluid status. ImpediMed produces a family of FDA cleared and CE Marked medical devices, including SOZO® for multiple indications including heart failure and lymphoedema, sold in select markets globally.

Toft Group Completes Search for Vice President, Information Technology for Synthetic Genomics, Inc. (SGI), in La Jolla, CA

Executive search firm Toft Group has placed Timothy E. Cooley as Vice President, Information Technology at Synthetic Genomics, Inc. (SGI), in La Jolla, CA.

Mr. Cooley has many years of experience in leading information technology in life sciences companies. He has previously served as Director of Business Solutions for MPI Research, Executive Vice President of US Operations at Molecular Health, and CIO for NAMSA. He also volunteers as Chief Data Officer for the Human Health Project. Earlier in his industry career Mr. Cooley spent 15 years with Eli Lilly where he held several roles, most recently as their Director of Information Technology, Medical and Health Outcomes.  Mr. Cooley holds a BS in Microbiology from Texas A&M University

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Synthetic Genomics, Inc.

Synthetic Genomics, Inc. (SGI) is a private biotechnology company harnessing the power of living cells — nature’s most efficient machines — to create transformative medicines and bio-based products. With an unmatched understanding of how DNA and RNA instruct the functions of life, we program cells for improved purpose and function. Our R&D competencies focus on our novel self-amplifying RNA replicon platform for infectious disease and oncology vaccines and therapeutics and our algal cell systems for industrial and biotherapeutic discovery and manufacturing. Built on a legacy of scientific firsts, our team of biological engineers are shaping the future bioeconomy.

Toft Group Completes Search for Chief Financial Officer for aTyr Pharma, Inc. (Nasdaq: LIFE) in San Diego, CA

Executive search firm Toft Group has placed Jill Broadfoot as Chief Financial Officer at aTyr Pharma, Inc. in San Diego, CA. aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways.

Prior to joining aTyr Ms. Broadfoot served as Chief Financial Officer of Emerald Health Pharmaceuticals Inc. and Emerald Health Bioceuticals Inc. where she was responsible for establishing operations for the U.S.-based pharmaceutical and bioceuticals entities as well as the establishment of operations, corporate governance, finance and accounting and investor relations functions. Prior to Emerald Health, Ms. Broadfoot served as Vice President, U.S. Corporate Controller at GW Pharmaceuticals plc, and as Chief Financial Officer of Vical Inc. Before joining Vical, Ms. Broadfoot held various positions at DJO Global, Inc., most recently as Vice President of Finance. Ms. Broadfoot also served as an audit manager at Ernst & Young LLP. Ms. Broadfoot holds a B.S. in business administration and accounting from San Diego State University and is a Certified Public Accountant.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About aTyr

aTyr is a clinical-stage biotechnology company engaged in the discovery and clinical development of innovative medicines using its knowledge of tRNA synthetase biology. aTyr is focused on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase (HARS) gene family. aTyr’s clinical stage ATYR1923 candidate augments the Resokine pathway and is designed to temper immune engagement in interstitial lung diseases. aTyr has built an intellectual property estate, to protect its pipeline, comprising over 250 issued patents or allowed patent applications that are owned or exclusively licensed, including over 300 potential protein compositions derived from tRNA synthetase genes.

Toft Group Completes Search for Vice President, Biotherapeutics Research & Development for Codexis, Inc. (NASDAQ: CDXS), in Redwood City, CA

Executive search firm Toft Group has placed Hicham Alaoui, Ph.D. as Vice President, Biotherapeutics Research & Development for Codexis, Inc. in Redwood City, CA.

Dr. Alaoui has more than 20 years of experience with drug discovery and development organizations. Most recently Dr. Alaoui served as Senior Vice President, Discovery Biology and co-head of Research at Symic Bio. Prior to Symic Bio, Dr. Alaoui worked at Genentech, ultimately leading a large in vitro pharmacology group dedicated to lead discovery and optimization for both biotherapeutic and small molecule programs. Prior to Genentech, he worked in R&D leadership positions at Stryker Biotech, VisEn Medical, Neogenesis Pharmaceuticals, and Shire BioChem.

Dr. Alaoui earned a Ph.D. in Microbiology and Immunology at McGill University, Montreal, Quebec, and an M.Sc. in Biochemistry from Pierre and Marie Curie Université, Paris.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Codexis, Inc.

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Toft Group Completes Search for Member, Board of Directors for Cell Medica in Houston, TX

Executive search firm Toft Group has placed Julia P. Gregory as Non-Executive Director and Audit Chair of Board of Directors for Cell Medica in Houston, TX.

Ms. Gregory has extensive experience in senior roles in the biopharmaceutical industry as well as more than 20 years of investment banking experience.  She currently serves as a non-executive director of several biopharmaceutical companies, including Sosei Group Corporation and Biohaven Pharmaceuticals.  Ms. Gregory is also Chairman and CEO of the biotechnology financial and management advisory firm Isometry Advisors, Inc.

In her previous executive roles, Ms. Gregory served as Chief Executive Officer, Chief Financial Officer and Board Director of ContraFect Corporation; President and CEO of Five Prime Therapeutics; and Executive Vice President, Corporate Development and Chief Financial Officer of Lexicon Pharmaceuticals, Inc.  Her corporate development experience includes leading transactions with GlaxoSmithKline, Human Genome Sciences, Genentech, Bristol-Myers Squibb Company and Takeda Pharmaceutical.

Prior to working in the biopharmaceutical industry, Ms. Gregory was an investment banker. Ms. Gregory has also served on the Board of Directors at The Global TB Alliance for Drug Development, Clinipace Worldwide, and the Institute for the Study of Aging, a private foundation for Alzheimer’s.

Ms. Gregory holds an MBA from the Wharton School at the University of Pennsylvania and a BA from George Washington University.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Cell Medica

Cell Medica is committed to transforming patients’ lives through developing the significant therapeutic potential of cellular immunotherapy for the treatment of cancer. In collaboration with strategic partners, Cell Medica is developing a range of products using three proprietary technology platforms including activated T cells, chimeric antigen receptors (CARs) and engineered T cell receptors (TCRs). Cell Medica’s lead product is CMD-003 and is being tested in an international Phase II trial for the treatment of cancers associated with the oncogenic Epstein Barr virus. Cell Medica is working with the Baylor College of Medicine and the University of North Carolina to develop next generation CAR- modified NKT cells including an off-the-shelf product. In the field of engineered TCRs, they are collaborating with University College London to develop the Dominant TCR technology platform.

Cell Medica is headquartered in London with subsidiaries in Zurich and Houston.

Toft Group Completes Search for Director of Marketing, Quality Systems Division for Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), in Irvine, CA

Executive search firm Toft Group has placed Ms. Nicola Zahl as Director of Marketing, Quality Systems at Bio-Rad Laboratories, Inc.

Ms. Nicola Zahl is the former Vice President of Marketing for Human Longevity, Inc. During this time, she built their marketing and sales structure in addition to leading branding, ecommerce and product launches for this startup genomics company. She previously worked as Vice President of Marketing for Pediatric Bioscience and oversaw the global marketing strategy for this testing service company developing a proprietary test to facilitate earlier diagnosis and improved treatment for children with autism. Ms. Zahl was the Vice President and Co-Founder of SoCal EED, a nonprofit that manages seed accelerators and business incubators for startups in Southern California. She offered mentoring to companies in business planning, marketing strategy, and execution. Ms. Zahl has also held leadership positions at Life Technologies, Invitrogen, and the biosciences division of Becton Dickinson.

Ms. Zahl holds an MBA in Managing Innovation and Marketing from Santa Clara University and a BA in Political Science/Biology from the University of California, San Diego.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide.

Toft Group Completes Search for Vice President, Medical Affairs for Nektar Therapeutics (Nasdaq: NKTR) in San Francisco, CA

Executive search firm Toft Group has placed Dr. Karin Tollefson as Vice President, Medical Affairs at Nektar Therapeutics in San Francisco, CA.

Dr. Tollefson received her Doctorate in Pharmacy from the University of Kansas and has spent most of her career in pharmaceutical research and development with a particular emphasis on oncology research. She was most recently Senior Director of Oncology Medical Affairs and Clinical Development at Eli Lilly and Company. Through her tenure at Eli Lilly and Company, she has held several leadership positions centered on developing and registering innovative medicines for patients seeking treatment. Her experience with lung cancer research and involvement in the thoracic research community introduced her to the local leadership of the American Lung Association, where she became involved in the inaugural programs focusing on lung cancer research and prevention.

Dr. Tollefson’s volunteer efforts have focused on advocating for the needs of cancer patients and caregivers through involvement in the state and national advocacy and professional relations organizations that serve them. Currently Ms. Tollefson serves on the Board of the American Lung Association of Indiana; the Executive Leadership Committee for the Indiana American Lung Association Stair Climb; the Board of Directors for the Indiana Leukemia and Lymphoma Society; and serves on several professional women’s mentoring networks.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Nektar Therapeutics

Nektar Therapeutics is a research-based development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar’s proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.

Toft Group Completes Search for Vice President of Pharmaceutical Solutions for Navigating Cancer in Seattle, WA

Executive search firm Toft Group has placed Ms. Stacy Mecham as Vice President of Pharmaceutical Solutions at Navigating Cancer in Seattle, WA.

Ms. Mecham is a strategic business development leader with 15 years of pharmaceutical market research experience, primarily focused on oncology. She joined AlphaImpactRx prior to its acquisition by IQVIA/QuintilesIMS as Senior Vice President of the oncology franchise. Ms. Mecham previously served with Bristol-Myers Squibb as the Associate Director, Oncology Customer Insights. Prior to BMS Ms. Mecham was Vice President of oncology franchise for ImpactRx.  Earlier in her industry career, Ms. Mecham held roles in market research and business development for Verispan, LLC.

Ms. Mecham has a M.Ed in counseling psychology from Temple University and a BA in psychology from West Chester University of Pennsylvania.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Navigating Cancer

Navigating Cancer was founded in 2008 as the result of two healthcare and technology veterans coming together to fill a critical gap in oncology care: a better patient experience. Driven by a shared passion to leverage technology in the healthcare space, the co-founders set out to create the first patient-centered platform for oncology. Today, the Navigating Care platform supports over one million patients and thousands of cancer care providers nationwide to lower costs, improve patient satisfaction and drive better outcomes.

Toft Group Completes Search for Senior Director of Laboratory Operations for CareDx, Inc. (Nasdaq: CDNA) in Brisbane, CA

Executive search firm Toft Group has placed Ms. Mariko Matsutani as Senior Director of Laboratory Operations for CareDx Inc. in Brisbane, CA.

Ms. Matsutani is a licensed clinical laboratory scientist and medical technologist with over 25 years of experience in her field. She joined Trovagene in 2014 as Director of Clinical Laboratory Operations where she oversaw daily operations of a CLIA, CAP-accredited laboratory. Previously, Ms. Matsutani worked with Biotheranostics as an Administrative Director, Laboratory Operations. Ms. Matsutani served with Cypress Biosciences as their Director, Clinical Laboratory, oversaw the clinical laboratory of Prometheus Laboratories, and was a Senior Clinical Laboratory Scientist at Scripps Research Institute.

Ms. Matsutani holds a BS in medical technology from Northern Arizona University.

About CareDx

CareDx, Inc. (Nasdaq: CDNA), headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products along the pre- and post-transplant testing continuum.

Toft Group Executive Search Named in the Top 50 Recruiters in the Americas

June 4, 2018, San Diego, CA:  Toft Group, a global life sciences and healthcare executive recruiting firm, today announced it has been named one of the Top 50 Recruiters in the Americas by Hunt Scanlon Media, the most widely referenced global news source in the human capital sector. Hunt Scanlon recently presented its annual roundup of the largest, fastest-growing executive search firms in the Americas. These are the 50 top firms in this dynamic marketplace – ranging from the largest recruiting and talent leadership solutions firms to the leading boutique specialists.

The complete list of search firms was published in the Recruiters Rankingsspecial issue of the Hunt Scanlon Executive Search Review.

“Toft Group is honored to be recognized among the top recruiters,” commented Robin Toft, President & CEO of Toft Group. “As today’s talent gap has become a hiring crisis, the need for experienced and talented executive search professionals has grown. Our success comes from our team of highly experienced search consultants, our commitment to delivering exceptional results and our collaborative network of partners, clients, and candidates who share a passion for healthcare advancements and innovation.”

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston. For more information, visit www.thetoftgroup.com.

About Hunt Scanlon Media

Hunt Scanlon Media has been informing the senior talent management sector for over 25 years. Their global news and intelligence data comes in many forms, including daily newswires, talent leadership reports, newsletter briefings and social media alerts. The privately-held company is headquartered in Greenwich, Conn.